Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. Methods We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and April 2020. Among them, 223 patients had underlying dementia (dementia group). We matched 1:1 for each dementia- non-dementia group pair yielding 223 patients without dementia (no dementia group) using propensity score matching. Results Mortality rate after COVID-19 was higher in dementia group than in no dementia group (33.6% vs. 20.2%, p=0.002). Dementia group had higher proportion of patients requiring invasive ventilatory support than no dementia group (34.1% vs. 22.0%, p=0.006). Multivariable analysis showed that dementia group had a higher risk of mortality than no dementia group (odds ratio=3.05, p<0.001). We also found that patients in dementia group had a higher risk of needing invasive ventilatory support than those in no dementia group. Conclusion Our results suggest that system including strengthen quarantines are required for patients with dementia during the COVID- 19 pandemic.
Abstract
Objective Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. Methods We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and April 2020. Among them, 223 patients had underlying dementia (dementia group). We matched 1:1 for each dementia- non-dementia group pair yielding 223 patients without dementia (no dementia group) using propensity score matching. Results Mortality rate after COVID-19 was higher in dementia group than in no dementia group (33.6% vs. 20.2%, p=0.002). Dementia group had higher proportion of patients requiring invasive ventilatory support than no dementia group (34.1% vs. 22.0%, p=0.006). Multivariable analysis showed that dementia group had a higher risk of mortality than no dementia group (odds ratio=3.05, p<0.001). We also found that patients in dementia group had a higher risk of needing invasive ventilatory support than those in no dementia group. Conclusion Our results suggest that system including strengthen quarantines are required for patients with dementia during the COVID- 19 pandemic.
참고문헌 (31)
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019(COVID-19) : a review", JAMA, 324, pp.782~793 (2020)
- Tian W, "Predictors of mortality in hospitalized COVID-19 patients : A systematic review and meta-analysis", J Med Virol, 92, pp.1875~1883 (2020)
- Li X, "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan", J Allergy Clin Immunol, 146, pp.110~118 (2020)
- Yang JM, "Allergic disorders and susceptibility to and severity of COVID-19 : A nationwide cohort study", J Allergy Clin Immunol, 146, pp.790~798 (2020)
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Liao KM, "Dementia increases severe sepsis and mortality in hospitalized patients with chronic obstructive pulmonary disease", Medicine(Baltimore), 94, pp.e967~ (2015)
- Brunnstrom HR, "Cause of death in patients with dementia disorders", Eur J Neurol, 16, pp.488~492 (2009)
- "World Alzheimer’s report 2019: Attitudes to Dementia" (2019)[URL]
- Wang H, "Dementia care during COVID-19", Lancet, 395, pp.1190~1191 (2020)
- "News Release. September 1, 2020. targeted response urgently needed"[URL]
- Atkins JL, "Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort", J Gerontol A Biol Sci Med Sci, 75, pp.2224~2230 (2020)
- Docherty AB, "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", BMJ, 369, pp.m1985~ (2020)
- Sung H, "Preparedness and rapid implementation of external quality assessment helped quickly increase COVID-19 testing capacity in the Republic of Korea", Clin Chem, 66, pp.979~981 (2020)
- Kang J, "South Korea’s responses to stop the COVID-19 pandemic", Am J Infect Control, 48, pp.1080~1086 (2020)
- "Updated in Public health surveillance for COVID-19, published 7 August 2020. WHO COVID-19Case definition"[URL]
- "Case definition and people subject to testing (As of June 25, 2020)"[URL]
- Koh D, "Counting coronavirus disease 2019(COVID-19)cases : Case definitions, screened populations and testing techniques matter", Ann Acad Med Singap, 49, pp.161~165 (2020)
- Achterberg WP, "Pain management in patients with dementia", Clin Interv Aging, 8, pp.1471~1482 (2013)
- Poloni TE, "Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia : An Italian retrospective study", EClinicalMedicine, 26, pp.100490~ (2020)
- Fong TG, "The interface between delirium and dementia in elderly adults", Lancet Neurol, 14, pp.823~832 (2015)
- Diwell RA, "Key components of the delirium syndrome and mortality : greater impact of acute change and disorganised thinking in a prospective cohort study", BMC Geriatr, 18, pp.24~ (2018)
- Fotuhi M, "Neurobiology of COVID-19", J Alzheimers Dis, 76, pp.3~19 (2020)
- Coperchini F, "The cytokine storm in COVID-19 : An overview of the involvement of the chemokine", chemokine-receptor system, 2020, pp.53, 25~32
- Vargas G, "Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and glial cells : Insights and perspectives", Brain Behav Immun Health, 7, pp.100127~ (2020)
- Heneka MT, "Neuroinflammation in Alzheimer’s disease", Lancet Neurol, 14, pp.388~405 (2015)
- Perez-Nievas BG, "Deciphering the astrocyte reaction in Alzheimer’s disease", Front Aging Neurosci, 10, pp.114~ (2018)
- Wang L, "Coronavirus disease 2019 in elderly patients : Characteristics and prognostic factors based on 4-week follow-up", J Infect, 80, pp.639~645 (2020)
- Killen A, "The challenges of COVID-19 for people with dementia with Lewy bodies and family caregivers", Int J Geriatr Psychiatry, 35, pp.1431~1436 (2020)
- Needham EJ, "Neurological implications of COVID-19 infections", Neurocrit Care, 32, pp.667~671 (2020)
- Carod-Artal FJ, "Neurological complications of coronavirus and COVID-19", Rev Neurol, 70, pp.311~322 (2020)
- "COVID-19 Report 2020"[URL]